New Pharmacological Drug Classes Introduced in 2008
C1 inhibitor : is licensed for the routine prophylaxis against angioedema attacks in patiets with hereditary angioedema (HAE). Application for licensure as a treatment for acute angioedema attacks is pending.
No comments:
Post a Comment
Please add your comments or suggestions here..
Note: Only a member of this blog may post a comment.